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Stem cell differentiation is governed by extracellular signals that activate intracellular networks (or pathways) to drive phenotypic
specification. Using a novel gene clustering strategy we determined pathway relationships from a genome-wide transcriptional dataset of skeletal
myoblast differentiation. Established myogenic pathways, including cell contractility and cell-cycle arrest, were predicted with extreme statistical
significance ( p  0). In addition, gene sets associated with angiogenesis, neuronal activity, and mRNA splicing were regulated, exposing
developmental and therapeutic implications. Acquisition of transcriptional data spanning the entire differentiation time course provided context for
a dynamic landscape of functional pathway regulation. This novel perspective on myogenic cell differentiation revealed previously unrecognized
patterns of regulation. We predict that similar analyses will facilitate ongoing efforts to define molecular mechanisms in other stem cell and
developmental paradigms. Finally, by combining an iterative process of analysis with supplementation of novel pathways, this application may
evolve into a powerful discovery tool.
D 2005 Elsevier Inc. All rights reserved.Keywords: Myogenesis; Progenitor; Differentiation; Skeletal muscle; Stem cellCell differentiation involves a phenotypic shift toward a
more specialized functional state. This process is fundamental
to embryonic development, during which primitive stem cells
adopt lineage specification and terminal commitment [1].
Skeletal muscle development entails differentiation of somite-
derived progenitors that become myoblast intermediates before
terminal commitment to multinucleated myotubes that consti-
tute myofibers in postnatal musculature [2,3]. Critical to these
functional adaptations is gene expression regulation, which
correlates dynamically with the cell_s phenotype. For example,
in terminally differentiating myoblasts, genes such as sarco-
glycan and myoglobin that encode important functional
components of skeletal myotubes are upregulated. According-
ly, for all terminally differentiated cell types, a gene expression
signature that represents the combinatorial pattern of transcripts
and collectively defines the cell phenotype may be determined.
Numerous analyses of differentiating myoblasts have been0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ygeno.2005.08.009
* Corresponding author.
E-mail address: daniel.kemp@novartis.com (D.M. Kemp).performed in efforts to characterize myogenic cell specification
at the molecular level. Proteomic [4,5] as well as transcriptomic
[6–10] studies are frequently described in the literature,
wherein expression data are generally presented as a culmina-
tion of individually regulated genes. Consequently, such
analytic approaches achieve limited mechanistic penetration
with respect to the biological process in question. A notable
study by Zhao and Hoffman focused on pathway regulation in
regenerating muscle by performing an extensive time-point
series in damaged muscles of mice [11]. They showed that the
staged induction of myogenic regulatory factors that occur
during embryonic myogenesis is recapitulated by postnatal
muscle regeneration. The dynamic nature of that study
emphasized the complexity and sequential character of
phenotypic adaptation, but once again the analytic approach
restricted the functional conclusions. Other comparative
genome-wide studies of skeletal muscle have focused on the
physiological effects of aging [12], insulin sensitivity [13],
atrophy [14], inflammation [15], mitochondrial disorders [16],
and various other muscle diseases [17], leading to a compen-
dium of data that collectively characterize the key regulatory6) 129 – 138
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diseases. It is clear, however, that all of these studies would
benefit from the integration or unification of raw data within a
more functionally relevant analytic application, from which
nontrivial mechanistic prediction can be made. Indeed,
emerging opinion suggests that subtle variance in gene
expression may underlie significant functional events that
may be more readily revealed in a context of pathway-related
gene clusters [18,19]. Gene Set Enrichment Analysis (GSEA)
was designed to exploit this concept that functional regulation
manifests at the level of biological pathways or coregulated
gene sets, rather than as a function of individual genes. This
rationale was validated by Mootha et al. in the context of
oxidative phosphorylation in skeletal muscle of type 2 diabetes
patients [19]. Here, we applied a similar analytic approach to
the study of skeletal myogenic differentiation and investigated
the dynamic nature of C2C12 myoblast differentiation to
multinucleate myotubes. As predicted, this analytic approach
revealed that characteristic functions of myogenesis including
cell-cycle arrest [10,20], mitochondrial biogenesis [21,22], and
expression of myogenic factors [23] were correspondingly
regulated with differentiation. However, we also revealed novel
functional pathway regulation that included angiogenesis,
mRNA splicing, and neuronal activity-related pathways.
Moreover, we present data that suggest a novel oscillatory
pattern of gene set expression associated with the function of
oxidative phosphorylation, a key process in maintaining
metabolic balance within the myocyte [24]. The implications
of these findings are discussed, and the potential utility of this
experimental strategy in stem cell research is outlined.
Results
Gene expression profiling of C2C12 cell differentiation
The mouse C2C12 myoblast cell line was employed to
model late stage (terminal) myogenesis. Upon induction of
differentiation these mononucleate cells exited the cell cycle
and fused to form myotubes that physically contracted and
displayed characteristic molecular features of skeletal myo-
blasts (Fig. 1A). Regulation of gene expression during
differentiation substantiated this functional response as deter-
mined by DNA microarray analysis (Fig. 1B). Myoglobin,
utrophin, myogenin, Mef2c, sarcoglycan, myosin heavy chain,
and Glut4 were among a list of well-characterized myogenic
genes that displayed increased expression levels in C2C12
myotubes 5 days after induction of differentiation (Fig. 1B).
Conversely, cyclin B1 and cdc2a among other genes associated
with the cell cycle were transcriptionally repressed, consistent
with concomitant cell-cycle arrest. At the protein level, we also
determined the relative expression of myogenic genes between
undifferentiated and differentiated myoblasts. Whereas myo-
genin and h-enolase displayed marked increases in expression
(Fig. 1C), MyoD and Myf5 levels were both attenuated in
differentiated myotubes, consistent with their role in early
myogenic specification and satellite cell function, respectively
[25].Mitochondrial biogenesis is a critical pathway in myoblast
differentiation [21], involving replication (on a per cell basis) of
mitochondria prior to cell fusion. As such, pharmacological
inhibition of mitochondrial biogenesis has been shown to block
myogenic differentiation [22]. To demonstrate thismechanism in
our myogenic model we employed two reporter gene assays as
biomarkers for either differentiation or mitochondrial regulation.
A MEF2-responsive reporter construct was used as the differ-
entiation biomarker, which was robustly induced (5.5-fold)
during differentiation (Fig. 1D), consistent with the upregulation
of endogenous genes such asMef2c (Fig. 1B). In the presence of
the myogenic inhibitory factor BMP4 [26], cell-cycle arrest was
precluded, andmyotubes were absent within the cell culture over
the 5-day differentiation period (data not shown). This was
reflected by the MEF2-responsive reporter gene, which was
refractory to the differentiation conditions in the presence of
BMP4 (Fig. 1D). The dynamics of mitochondrial biogenesis
were assessed by a second reporter gene under the transcriptional
control of the Ppargc1a gene promoter. PGC-1a is a transcrip-
tional coactivator that plays a direct and pivotal role in driving
mitochondrial biogenesis in vivo, and as such, expression of
Ppargc1a has been shown to track consistently with increased
mitochondrial number and function [27,28]. As predicted, the
PGC-1a reporter genewas significantly induced in differentiated
myotubes (approximately 30-fold), and this response was
attenuated in the presence of BMP4 (Fig. 1E). Collectively,
these data exemplify the defining characteristics of myogenic
specification and support the assumption that C2C12 cells
display many of the phenotypic markers of skeletal myocytes.
Pathway analysis of myoblasts and myotubes
To test whether C2C12 cell differentiation was amenable to
GSEA, we employed gene sets that represented known cellular
functions of myogenic specification (Fig. 2). Gene sets were
mined from various publicly and privately available databases,
and methodologies for the creation of functional pathways
varied. In total, 789 gene sets comprised the collection used in
this study. Cell-cycle and muscle contraction were selected as
two well-characterized functional pathways of skeletal muscle
cells and their gene sets consisted of 644 and 108 individual
probes, respectively (Table 1). In each case, the genes within a
set were predicted to constitute a significant proportion of the
relevant transcripts involved in a given functional pathway.
Subtractive analysis of whole-genome microarray-derived
transcriptional expression levels was carried out to determine
variation in pathway function between C2C12 myotubes and
myoblasts. As expected, the exit from the cell cycle during
differentiation of myoblasts was reflected in a clear negative
shift in gene set expression (Fig. 2, top). In contrast, the muscle
contraction gene set was significantly upregulated in differen-
tiated myotubes ( p  0) (Fig. 2, middle).
Other gene sets exhibiting significant changes in expression
upon cell differentiation are listed in Table 1. Gene sets
associated with cell division were well represented overall, and
all functional pathways in this family were decreased as
expected. Gene sets associated with DNA metabolism, DNA
Fig. 1. C2C12 cell differentiation and coordinate gene expression changes. (A)Bright-field image ofC2C12 cells in culture (top) and 5 days postdifferentiation (bottom).
(B) Expression levels of a selection of myogenic genes following differentiation of C2C12 cells relative to levels in predifferentiated myoblasts. (C) Western blots of
muscle-specific proteins in myoblasts (MB) and myotubes (MT). Tubulin serves as a control for protein loading. (D, E) Luciferase reporter gene assays showing the
effects of differentiation on a MEF2-responsive promoter (D) and 2 kb of the PGC-1a gene promoter (E) in the absence or presence of the myogenic antagonist BMP4.
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myotubes, presumably a direct consequence of inhibition of cell
division. Several less anticipated pathways were noteworthy
within this comparative analysis, including some that previously
have not been linked directly with myogenic cell differentiation
(Table 1). A selection of these gene sets is represented in Fig. 3,
in dot-plot format that captures the total set of probes and their
respective regulation variance between pre- and postdifferen-
tiated myoblasts.
Although statistically less significant than the gene sets for
muscle contraction and cell cycle (primarily due to probe set
size), the angiogenesis gene set displayed a convincing
upregulation in differentiated C2C12 cells versus undifferen-
tiated myoblasts ( p = 5  107) (Fig. 3B). The mRNA
splicing gene set showed a clear downregulation in expres-
sion, suggestive of functional implications of splice variation
in the context of myogenesis (Fig. 3F). Moreover, the gene
set associated with neuronal activity showed striking regula-
tion in differentiated myotubes with a significant increase inexpression level (Fig. 3E). In summary, the analysis revealed
statistically significant trends in functional pathways, which
have been overlooked in similar experimental paradigms with
traditional expression profiling approaches. Two related
pathways that displayed marked shifts in expression were
cell communication and adhesion-mediated signaling (Figs.
3A and 3D). Though predictable given the nature of the
experiment involving cell fusion, such pathway recognition
has not been clearly demonstrated previously to our
knowledge.
Next, to capture a dynamic profile of pathway expression, we
applied the pathway analysis to data generated from sequentially
isolated mRNA samples through 5 days of differentiation. Fig. 4
depicts the dynamic nature of differentiating C2C12 cells
from proliferating myoblasts, through induction, to terminally
differentiated myotubes. The selected genes displayed in Fig. 4
represent well-characterized myogenic markers whose expres-
sion and function in skeletal muscle cells are tightly controlled.
The data faithfully reflected the dynamic variation in gene
Fig. 2. Comparative gene set analysis of differentiated myotubes vs myoblasts. Distribution in myogenic gene sets during differentiation of C2C12 cells, wherein all
probes represented in the respective gene sets are presented as an expression ratio. Frequency ( y axis) represents the number of probes in each gene set with the
corresponding expression ratio (x axis). The mean expression ratio for the muscle contraction gene set and the cell-cycle gene set varies relative to the total gene set
with the statistical significance indicated.
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within the differentiating myocyte. Cell-cycle arrest during
differentiation was reflected by a decrease in cyclin D1
transcription with a concomitant elevation in the cell-cycle
inhibitor gene p21 (Fig. 4A). Expression of the transcription
factor genes myogenin and Mef2, which play a central role in
driving cellular phenotype of skeletal myotubes, was clearly
elevated (Fig. 4B). Similarly, Glut4, creatine kinase, and
nicotinic receptors, all phenotypic markers of terminally
differentiated muscle cells, also were increased significantly
throughout the period of differentiation (Fig. 4C).
Finally, we applied pathway analysis to this temporal
expression dataset of differentiating C2C12 myoblasts with the
goal of identifying pathway regulation as a function of time. Fig.
5 shows the temporal variation of five functional pathways. Both
muscle contraction and angiogenesis pathways were determined
to increase consistently over the 5 days of differentiation (Fig.
5A). In contrast, the cell-cycle and DNA repair gene sets
displayed a significant decrease in expression over the same
period (Fig. 5B). However, two independent gene sets associated
with the function of oxidative phosphorylation displayed a
discrete yet statistically significant pattern of expression. Though
positive overall (day 1 vs day 5), the temporal pattern
suggested an oscillatory profile in oxidative function (Fig. 5C).This unexpected finding warrants further experimental valida-
tion before functional relevance can be determined.
Phase-transition pattern of gene expression during C2C12
differentiation
We analyzed the total gene expression profile from the
differentiation time-course data. When presented as a single
dataset, a clear transition phase could be observed between days 1
and2postdifferentiation(Fig.6A).Atthis timepoint,anaggregate
regulation in gene transcription was evident, reflected in an
apparentwholesale inversion in expression pattern (Figs. 6A, 6B,
and 7). By clustering all the probes across all time points, and
aligning them by similarity, it was evident that a transitional
expression pattern was defined between days 1 and 2 (Fig. 6B).
Also, by grouping the gene sets from Fig. 5 on a single graph, it
appeared that the transition phase could also be captured, as the
relative phase change between the functional pathway activities
also occurred between days 1 and 2 postdifferentiation (Fig. 6C).
Generation of novel pathway gene sets
Fig. 7 depicts a compilation of genes regulated most
significantly during the transition phase. The coordinated
Table 1
Significantly modulated gene sets during myogenic differentiation
Gene set Probe p value Direction
Cell division Cell cycle 644 6  10– 28 Down
Mitosis 210 4  10– 11 Down
G1–S checkpoint 81 2  10– 09 Down
Spindle checkpoint 16 1  10– 08 Down
Chromosome
segregation
64 2  10– 07 Down
G2–M checkpoint 12 4  10– 08 Down
Genome/DNA DNA metabolism 259 3  10– 29 Down
DNA replication 106 1  10– 22 Down
DNA repair 130 3  10– 13 Down
Gene
expression/
nucleus
mRNA splicing 175 2  10– 08 Down
Pre-mRNA processing 238 2  10– 07 Down
Nuclear transport 97 9  10– 07 Down
Protein modification 813 7  10– 06 Down
Intracellular
activity
Muscle contraction 108 ¨0 Up
Neuronal activities 174 4  10– 09 Up
Angiogenesis 22 5  10– 07 Up
Pentose phosphate
pathway
29 9  10– 07 Down
Mesoderm development 214 1  10– 06 Up
Extracellular
activity
Cell communication 444 ¨0 Up
Ligand-mediated
signaling
171 2  10– 11 Up
Cytokine–cytokine
receptor interaction
95 3  10– 10 Up
Synaptic transmission 62 2  10– 08 Up
Cell adhesion 226 5  10– 06 Up
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constitute novel functional pathways, regulated by an unde-
fined transcriptional mechanism. The new gene sets could be
added to the total collection of gene sets and subsequently
applied to distinct experimental studies. A subset of genes
from each of these highly regulated gene sets is listed in Table
2, from which some known and unknown myogenic genes can
be identified. Though these genes may not be regulated by a
common transcriptional program, their coincident expression
pattern in this study is striking and may warrant further
investigation.
Finally, a secondary level of expression regulation could
be ascertained within these new gene sets related to the
specific induction of differentiation of C2C12 myoblasts. In
response to the switch in cell culture conditions at day 0, a
clear, yet transient, response in gene expression was
observed. This effect was most obvious between day 0 and
day 0.25, during the first 6 h of myogenic differentiation. At
this time many genes appeared to respond with a refractory
shift in expression, which was likely a direct result of
induced cell shock. With respect to the total gene set, this
effect was transient and was essentially reversed by day 1
postdifferentiation.
Discussion
Skeletal muscle exists in a constant state of equilibrium,
balancing low-level atrophy with a generally equal measure of
regeneration. But under certain physiological circumstances
the potential for instability of these opposing processes isrevealed with impressive consequences. The degree of muscle
atrophy during a period of bed rest or immobilization can be
profound, and in contrast, the regeneration of atrophied muscle
during rehabilitation can be equally striking. The basis for
such rapid adaptability in skeletal muscle mass derives
partially from the prolific nature of resident muscle stem cells
(also known as satellite cells), which can be activated to
induce muscle regeneration [29]. Many studies have added
mechanistic clarity to the process of satellite cell activation
and differentiation. For example, the role of the Notch
signaling pathway within the satellite cell compartment has
gained recent attention as a critical factor in regenerative
activation [30]. Moreover, the relative absence of Notch
signaling in aged individuals who present with decreased
regenerative capacity further substantiates this concept [31], to
the extent that rejuvenation of aged satellite cells by exposure
to a young systemic environment also reconstitutes the Notch
signaling pathway in these cells [32]. Here, we used C2C12
muscle progenitor cells to model the myogenic differentiation
in an effort to uncover novel pathways that may represent
therapeutic targets in the context of skeletal muscle diseases.
Defining cell behavior as a function of pathway expression is
likely to prevail as a model for identifying mechanisms of
disease, as well as understanding developmental conditions
[33]. The improved biological context and statistical strength
associated with pathway analyses versus individual gene
expression promises to be definitive in instances of disease
phenotypes that often reflect only subtle changes at the
cellular and molecular levels. This hypothesis is supported
by the fact that chronic diseases such as type 2 diabetes derive
from complex genetic traits that predispose the patient to
symptomatic onset through diverse environmental cues [34].
The current study was designed to employ the statistical power
of functional pathway analysis and to reveal novel mechan-
isms within the differentiating myogenic progenitor. Gene Set
Enrichment Analysis of C2C12 cell differentiation predicted
that angiogenesis signals were activated in differentiating
muscle cells. Such a concept is consistent with the fact that
regenerating skeletal muscle, as well as embryonic muscle
development, requires extensive vascularization to support
metabolic and mechanical function. We also observed a
statistically significant increase in the gene cluster underlying
neuronal activity signaling, consistent with the requirement of
developing muscle to evolve neuromuscular junctions for
electrical excitation and contractility, of which both were
represented significantly in this study via upregulation of their
respective gene sets. An apparent decrease in mRNA splicing-
related gene expression presents an intriguing aspect that
warrants further investigation in the myogenic context and
also in the general context of stem cells. Whether myogenic
differentiation is dependent on an orchestrated pattern of
mRNA splice variation is unknown, but a role for such
phenotypic regulation is attractive. Though somewhat prema-
ture, it is tempting to speculate a general role for splicing
events in stem cell differentiation [36].
We extended the study to introduce a temporal component
to reveal insights in the step-by-step progression of differen-
Fig. 3. Dot-plot representations of gene set enrichment as a function of C2C12 cell differentiation. The x axis of each plot represents expression levels in myoblasts (at
day1), and the y axis represents differentiated myotubes (at day 5). Each dot represents a single probe on the GeneChip. The total probe set (gray dots) and the specific
gene set (blue dots) are presented on the same plot to give direct perspective of gene set regulation. (A–F) various gene sets that were analyzed and corresponded with
significant expression changes.
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characterizing pathways and regulatory patterns that are
associated with differentiation of stem cells, there remains
much uncertainty as to the true relationships of molecular
events that contribute to intracellular function. Here, we
defined the temporal profile of numerous (predetermined)
pathway-related gene sets during differentiation. In addition to
demonstrating a consistent increase in contractility-related gene
expression, and a consistent decrease in cell-cycle-related gene
expression over time, the analysis revealed an unexpected
profile of the oxidative phosphorylation gene set. An apparent
oscillatory pattern was observed, for which an explanation is
not readily available. If validated by functional investigation,
this finding may add a novel perspective to the role of
oxidative phosphorylation and fatty acid metabolism in the
process of myogenic differentiation.
The limitations of the analyses employed in this study
derive from the predetermination of pathway gene sets.
Consequently, the extent of novelty drawn from this study
was limited to the novel implication of known pathways in the
context of myoblast differentiation. However, by the reiterative
process of data acquisition, creation of novel gene sets, and
application to diverse expression-based studies, novel func-
tional pathways may emerge over time. We initiated thisconcept here by clustering genes that were coordinately
regulated between days 1 and 2 postdifferentiation. Indeed,
this time point appeared to reflect a transitional switch, wherein
two substantial subsets of genes underwent significant and
reciprocal transcriptional regulation. Whether these coregulated
gene clusters represent novel functional pathways that translate
to other experimental paradigms will require further investiga-
tion. We propose that the experimental approach presented here
may expedite our understanding of biological processes in both
disease and development.
Materials and methods
Cell culture
C2C12 mouse skeletal myoblasts were cultured in DMEM high glucose
with 10% FBS and 1% penicillin/streptomycin (Gibco) and maintained at 37-C
and 5% CO2. Differentiation of C2C12 myoblasts into myotubes was achieved
by culturing cells in medium containing reduced serum concentration (2% v/v)
for up to 5 days with medium changes every 2 days.
Gene expression profiling
C2C12 cell RNA was harvested using the RNeasy Midiprep kit (Qiagen)
following the manufacturer_s instructions. Cells were cultured in six-well plates
and a time course of differentiation was performed. Induction of differentiation
Fig. 4. Temporal gene expression profiles of differentiating C2C12 myoblasts.
Functionally related genes (A) of the cell cycle, (B) of transcription factors, and
(C) of phenotypic markers.
Fig. 5. Dynamic pathway analysis of differentiating C2C12 myoblasts. Selected
gene sets were applied to the data and are presented here as a time course of
relative expression. (A) Increasing expression gene sets. (B) Decreasing
expression gene sets. (C) Two separate gene sets associated with oxidative
phosphorylation, derived from either Mootha et al. [19] or the Celera database.
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concentration in the wells to 3% v/v. Cells were lysed for RNA preparation at
days 1, 0, 0.25, 1, 2, 3, 4, and 5 postdifferentiation. RNAwas analyzed using
the Affymetrix mouse whole-genome microarray, MOE430 Plus 2.0. Each time
point was performed in triplicate, from independent experiments.
Reporter gene constructs
Complementary oligonucleotides encompassing the MEF2 site from the
mouse desmin enhancer [35] with HindIII and XhoI sites on either end were
synthesized and annealed. The sequence of the top strand (MEF2 site underlined)
was desmin , GGCCTTTCCTTCTCCTCTATAAATACCAGCTCTGG-
TATTTCA. The oligonucleotides were ligated and cloned into the HindIII and
XhoI sites of the pLuc-MCS luciferase reporter cloning plasmid (Stratagene).
The number of inserts in the resulting plasmids was determined by DNA
sequencing. The PGC-1a promoter-driven luciferase reporter construct was akind gift from Dr. Bruce Spiegelman (Harvard Medical School, Boston, MA,
USA). The construct contained a 2-kb sequence of the upstream promoter region
of human PGC-1a.
Reporter gene assays
Undifferentiated C2C12 cells were harvested from 75-mm flasks to 100-
mm plates (Falcon) and immediately transfected while still in suspension. For
transient transfection, 25 Al of Fugene, along with 800 Al of OptiMem, 5 Ag of
reporter gene plasmid, and 0.5 Ag of Renilla luciferase reporter gene plasmid,
was prepared as recommended by the manufacturer. Culture plates were then
left overnight at 37-C to allow for efficient transfection. Cells were trypsinized,
harvested, and split into 24- or 96-well plates, carefully calculated for
immediate confluency upon adherence of the cells. Dependent on individual
Fig. 6. Whole-genome expression profile of C2C12 differentiation displays a marked transition between day 1 and day 2 of differentiation. Probes are color-coded for
clarity—red, downregulated >3-fold; blue, upregulated >3-fold; yellow, others. (A) Overlay of dynamic expression profiles of all probes on the Affymetrix gene chip
during differentiation. (B) Gene clusters of entire dataset as a function of time. Clusters are positioned in order of relative similarity of gene expression values. (C)
Data from Fig. 5 compiled onto a single graph to emphasize transitional phenotypic behavior between days 1 and 2 postdifferentiation.
Fig. 7. Potential novel gene sets. (A)Overlay of genes that display a >3-fold decrease in transcriptional expression between day 1 and day 2 postdifferentiation. The x axis
reflects the timecourseofdifferentiationand they axis reflects relative foldexpression. (B)Genes that increase>3-foldbetweendays1and2post-differentiation induction.
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Table 2
Genes highly regulated during the transitional phase between day 1 and day 2
post-differentiation induction
Down
Hemoglobin a
Tubulin
cdc25 homolog
FABP5
HSP4
Thymidine kinase 1
High mobility group box 2
neurofilament 3
Kinesin family member 22
Oxysterol binding protein 2
Stathmin-like 2
Neurofilament, light polypeptide
Kinesin family member 23
Serine hydroxymethyl transferase 1
Oxysterol binding protein 2
Gap 43
Cyclin E2
Myosin heavy chain IX
Deoxycytidine kinase
Hyaluronan-mediated motility receptor (RHAMM)
Serine/threonine kinase 12
Chromodomain helicase DNA binding protein 4
Centromere autoantigen A
Stathmin 1
Inhibitor of DNA binding 2
Thyroid hormone receptor interactor 13
Up
Glutathione peroxidase 3
Ceruloplasmin
Procollagen
Upregulated during skeletal muscle growth 4
NCAM1
Apolipoprotein E
Sortilin 1
Cadherin 11
Calsequestrin 1
Fibulin 5
FGF7
Follistatin
ERR g
Cysteine-rich protein 3
Myoglobin
Myosin, heavy polypeptide
Mitochondrial acyl-CoA thioesterase 1
Decorin
Ankyrin repeat domain 2
Lumican
Muscle glycogen phosphorylase
Ryanodine receptor 1
FGF-BP1
Cordon bleu
Actinin a2
Carboxylesterase 2
Mef2c
Osteomodulin
Microtubule-associated protein 4
Carbonic anhydrase 6
Neighbor of Punc E11
Angiopoietin
Fructosamine 3 kinase
Myomesin 2
Up
Myomesin 1
Dysferlin
Secreted frizzled-related sequence protein 2
Chemokine (C-X-C motif) ligand 12
Myozenin 2
CD36 antigen
Insulin-like growth factor 2
Chitinase 3-like 1
Transformation-related protein 63
Pleiotrophin
BMP4
ADP-ribosyltransferase 1
Solute carrier family 12, member 2
Table 2 (continued)
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added simultaneous with plating or cells were seeded in regular growth
medium, which was substituted the following morning by differentiation
medium. After 48 h of incubation, cells were harvested in lysis buffer and
frozen at 80-C until analyzed. The luciferase assay was performed as
instructed by the manufacturer of the Dual Luciferase Assay Kit (Promega).
Luminescence was determined using a luminescence plate reader with dual-
injection capability (Perkin–Elmer). Data were analyzed using Microsoft
Excel, and figures were generated using GraphPad Prism4 software.
Whole-cell protein extract preparation
Cells were washed twice with PBS and resuspended in 300 Al RIPA buffer
(50 mM Tris–HCl, pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM PMSF, 1 Ag/ml aprotinin, 1 Ag/ml leupeptin, 1 Ag/ml
pepstatin, 1 mM Na3VO4, 1 mM NaF). Lysates were vortexed for 10 min at 4-C
and then centrifuged at 14,000 rpm for 10 min to remove insoluble material.
Immunoblotting
Total protein concentration was assayed using the Bio-Rad DC Protein
Assay Kit per the manufacturer_s instructions. Eight micrograms total protein
was loaded per lane on a 4–12% Bis-Tris gel. Proteins were transferred onto
polyvinylidene difluoride membranes and probed with the following anti-
bodies: h-enolase, 1:1000 (mouse monoclonal; BD Transduction Laboratories);
MyoD clone 5.8A, 1:1000 (mouse monoclonal; BD Pharmingen); myogenin,
1:1000 (mouse monoclonal; BD Pharmingen); Myf-5, 1:1000 (rabbit poly-
clonal; Santa Cruz Biotechnology); and tubulin, 1:2000 (mouse monoclonal;
Abcam). The respective horseradish peroxidase-conjugated secondary anti-
bodies were used at 1:5000 dilutions (Bio-Rad). Signals were developed using
an ECL kit (Amersham Biosciences).
Gene set enrichment analysis
An in-house implementation of the Gene Set Enrichment Analysis method
was used to analyze microarray data [19]. As input, GSEA requires microarray
data from two conditions to be compared (e.g., myoblasts vs myotubes). Genes
with expression levels below 100 on more than 75% of the GeneChips were
discarded. Then, the relative expression level under condition1 and condition2
was computed as an expression ratio ri,
ri ¼ li;1
li;2
;
where Ai,j is the average expression value for gene i under conditionj. Genes were
then sorted according to their expression ratios and listed. Next, the collection of
available gene sets was projected onto the sorted gene list. In essence, this step
applies a priori biological knowledge to the experimental data to identify
functionally related genes that are expressed in a coordinated fashion. Gene sets
were processed individually. For gene set G each expression ratio ri is labeled
J.D. Szustakowski et al. / Genomics 87 (2006) 129–138138‘‘in’’ the gene set if genei Z G and ‘‘out’’ of the gene set if genei u G. A two-
tailed Wilcoxon rank-sum test was then calculated to determine if the genes
labeled ‘‘in’’ gene setG were enriched at either the top or the bottom of the sorted
list. The output fromGSEA is a list of p values ( p1, p2, . . . , pN) and labels (l1, l2,
. . . , lN), liZ (top, bottom) that correspond to theN available gene sets. A small p
value pi indicates that the genes in gene setGi are significantly enriched at either
the top or the bottom of the list of expression ratios.
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